"The voice for cancer physicians and their patients in Massachusetts."
Novartis announced that the US Food and Drug Administration (FDA) approved Scemblix® (asciminib) for the treatment of chronic myeloid leukemia (CML) in two distinct indications. More Information.
© Copyright. All rights reserved.
Massachusetts Society of Clinical Oncologists
P.O. Box 549154, Waltham, MA, 02454
Tel: 781.434.7329 | Fax: 781.464.4896 | email: email@example.com